Transient Intraocular Pressure Fluctuations After Intravitreal Bevacizumab Injection in Proliferative Diabetic Retinopathy Patients: A Prospective Study

Introduction: The clinical use of intravitreal bevacizumab (IVB), a recombinant humanized monoclonal antibody that functions as an anti-vascular endothelial growth factor (anti-VEGF), has recently increased in patients with retinal ischemic diseases such as proliferative diabetic retinopathy (PDR)....

Descripción completa

Detalles Bibliográficos
Autores principales: Luqman, Faizan, Bibi, Hafsa, Mukhtar, Marwa, Zafar, Fahad, Ahmed, Hafsa, Khizer, Muhammad A, Gul, Nazli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Preventive Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578873/
https://www.ncbi.nlm.nih.gov/pubmed/37849604
http://dx.doi.org/10.7759/cureus.45371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578873/
https://www.ncbi.nlm.nih.gov/pubmed/37849604
http://dx.doi.org/10.7759/cureus.45371

Ejemplares similares